Cargando…

The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository

BACKGROUND: Psoriasis is a serious and chronic noncommunicable disease. However, the fundamental measure of disease occurrence, the incidence, has been scarcely reported globally. There are no previous studies of psoriasis incidence in Latin America. AIM: To estimate the incidence rates of psoriasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecaros, C., Dunstan, J., Villena, F., Ashcroft, D. M., Parisi, R., Griffiths, C. E. M., Härtel, S., Maul, J. T., De la Cruz, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518053/
https://www.ncbi.nlm.nih.gov/pubmed/33914930
http://dx.doi.org/10.1111/ced.14713
_version_ 1784584140454100992
author Lecaros, C.
Dunstan, J.
Villena, F.
Ashcroft, D. M.
Parisi, R.
Griffiths, C. E. M.
Härtel, S.
Maul, J. T.
De la Cruz, C.
author_facet Lecaros, C.
Dunstan, J.
Villena, F.
Ashcroft, D. M.
Parisi, R.
Griffiths, C. E. M.
Härtel, S.
Maul, J. T.
De la Cruz, C.
author_sort Lecaros, C.
collection PubMed
description BACKGROUND: Psoriasis is a serious and chronic noncommunicable disease. However, the fundamental measure of disease occurrence, the incidence, has been scarcely reported globally. There are no previous studies of psoriasis incidence in Latin America. AIM: To estimate the incidence rates of psoriasis in Chile during 2016 and 2017 using an administrative database, the Waiting List Repository. METHODS: We examined referrals of psoriasis at onset, made by physicians to dermatologists, evaluated the agreement of diagnosis, and estimated the incidence of the disease considering the eligible population at risk. RESULTS: In most cases, the referrals corresponded to incident cases of psoriasis (73.3%; 95% CI: 66.6–79.2). The national incidence rates of psoriasis were 22.1 (95% CI: 21.1–23.1) and 22.7 (95% CI: 21.8–23.6) per 100 000 person‐years in 2016 and 2017, respectively. The most common type of psoriasis was the late‐onset type. We observed a high variation in the figures throughout the country, with a range from 0.75 (95% CI: 0.3–1.5) per 100 000 person‐years in the Metropolitan region to 164.9 (95% CI: 138.6–195.1) per 100 000 person‐years in the Aysen region. CONCLUSION: We describe for the first time the incidence of psoriasis in a Latin American country. Our findings could potentially guide collaborations to improve our global understanding of psoriasis in Latin America.
format Online
Article
Text
id pubmed-8518053
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85180532021-10-21 The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository Lecaros, C. Dunstan, J. Villena, F. Ashcroft, D. M. Parisi, R. Griffiths, C. E. M. Härtel, S. Maul, J. T. De la Cruz, C. Clin Exp Dermatol Original Articles BACKGROUND: Psoriasis is a serious and chronic noncommunicable disease. However, the fundamental measure of disease occurrence, the incidence, has been scarcely reported globally. There are no previous studies of psoriasis incidence in Latin America. AIM: To estimate the incidence rates of psoriasis in Chile during 2016 and 2017 using an administrative database, the Waiting List Repository. METHODS: We examined referrals of psoriasis at onset, made by physicians to dermatologists, evaluated the agreement of diagnosis, and estimated the incidence of the disease considering the eligible population at risk. RESULTS: In most cases, the referrals corresponded to incident cases of psoriasis (73.3%; 95% CI: 66.6–79.2). The national incidence rates of psoriasis were 22.1 (95% CI: 21.1–23.1) and 22.7 (95% CI: 21.8–23.6) per 100 000 person‐years in 2016 and 2017, respectively. The most common type of psoriasis was the late‐onset type. We observed a high variation in the figures throughout the country, with a range from 0.75 (95% CI: 0.3–1.5) per 100 000 person‐years in the Metropolitan region to 164.9 (95% CI: 138.6–195.1) per 100 000 person‐years in the Aysen region. CONCLUSION: We describe for the first time the incidence of psoriasis in a Latin American country. Our findings could potentially guide collaborations to improve our global understanding of psoriasis in Latin America. John Wiley and Sons Inc. 2021-06-26 2021-10 /pmc/articles/PMC8518053/ /pubmed/33914930 http://dx.doi.org/10.1111/ced.14713 Text en © 2021 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Lecaros, C.
Dunstan, J.
Villena, F.
Ashcroft, D. M.
Parisi, R.
Griffiths, C. E. M.
Härtel, S.
Maul, J. T.
De la Cruz, C.
The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository
title The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository
title_full The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository
title_fullStr The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository
title_full_unstemmed The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository
title_short The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository
title_sort incidence of psoriasis in chile: an analysis of the national waiting list repository
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518053/
https://www.ncbi.nlm.nih.gov/pubmed/33914930
http://dx.doi.org/10.1111/ced.14713
work_keys_str_mv AT lecarosc theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT dunstanj theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT villenaf theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT ashcroftdm theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT parisir theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT griffithscem theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT hartels theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT mauljt theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT delacruzc theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT lecarosc incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT dunstanj incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT villenaf incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT ashcroftdm incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT parisir incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT griffithscem incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT hartels incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT mauljt incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository
AT delacruzc incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository